In connection with the implementation of the project titled “Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”, by BS Biotechna SA, under contract no. 2022/ABM/06/00005-00 for co-financing of a commercial project as part of the Development Competition targeted or personalized medicine based on medicinal products based on nucleic acids and small-molecule compounds. The Ordering Party conducts market research regarding the costs of delivery and purchase of antibodies and chemical reagents.
In order to submit an offer, please read the detailed content of the announcement included in the “delivery” section and send the completed offer form and the assortment and price form (Excel).